{"id":3865,"date":"2026-04-07T05:01:53","date_gmt":"2026-04-07T05:01:53","guid":{"rendered":"http:\/\/blog.valuengine.com\/?p=3865"},"modified":"2026-04-07T05:01:53","modified_gmt":"2026-04-07T05:01:53","slug":"04-06-2026-valuengine-weekly-market-summary-commentary","status":"publish","type":"post","link":"http:\/\/blog.valuengine.com\/index.php\/04-06-2026-valuengine-weekly-market-summary-commentary\/","title":{"rendered":"04\/06\/2026 ValuEngine Weekly Market Summary &#038; Commentary"},"content":{"rendered":"<p><strong>Weekly Market Recap \u2013 Week Ending April 02, 2026<\/strong><\/p>\n<p>U.S. equity markets continued their upward momentum over the past week, with broad-based gains across major sectors led by technology, industrials, and small-cap stocks. Growth-oriented ETFs, such as the NASDAQ 100 and Technology Select Sector, stood out with strong advances that reflect renewed investor confidence in innovation-driven segments. Meanwhile, financials, materials, and communication services also posted solid gains, signaling a constructive risk-on environment. The notable exception was the energy sector, which faced pressure amid declining oil prices. This highlights a divergence in sector performance as markets re-calibrate expectations around global demand and macroeconomic trends.<\/p>\n<p style=\"text-align: center;\">Trade ValuEngine supported portfolio strategies, <a href=\"http:\/\/www.ValuEngineCapital.com\" target=\"_blank\" rel=\"noopener\">www.ValuEngineCapital.com<\/a><\/p>\n<p>In the below tables we use major ETF\u2019s as a proxy for some major indexes as well as each of the sector groups into which we divide the overall markets. Tracking these over time provides a more defined picture of the US markets than simply tracking major indexes. This is followed by notable individual stock movers over the past month, and finally our full strategy outlook.<\/p>\n<p><img loading=\"lazy\" class=\"wp-image-3866 aligncenter\" src=\"http:\/\/blog.valuengine.com\/wp-content\/uploads\/2026\/04\/260406-ETF-Performance-Table.png\" alt=\"\" width=\"936\" height=\"551\" \/><\/p>\n<p style=\"text-align: center;\">Free Trial: Direct Access to ValuEngine Research on over 5,000 stocks and 700 ETFs <a href=\"https:\/\/ww2.valuengine.com\/products-and-pricing\/\" target=\"_blank\" rel=\"noopener\">HERE<\/a><\/p>\n<p><img loading=\"lazy\" class=\"wp-image-3867 aligncenter\" src=\"http:\/\/blog.valuengine.com\/wp-content\/uploads\/2026\/04\/260406-Stock-Perfomance-Table.png\" alt=\"\" width=\"936\" height=\"422\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Strategy Note:<\/strong><\/p>\n<p>After a disastrous March for all the major foreign and domestic indexed ETFs invested in broad market indexes, US investors bought the dip last week.\u00a0 Nevertheless, we expect that most investors will see that as a \u201cdead cat bounce\u201d until more clarity is brought to the global geopolitical situation.\u00a0 \u00a0For ValuEngine, the best strategy we can promote is to stay the course in using data-driven tools for investment decisions, not fears of wars raging out of control while the US struggles to find an exit strategy.<\/p>\n<p>The good news is that our models now consider just 52% of the stocks we follow to be overvalued as compared with more than 65% six months ago.\u00a0 Stock recently upgraded to 4 (Buy) include: Natural resources provider Cadiz Inc. (<strong>CDZI<\/strong>); Biocrystal Pharmaceuticals Inc., (<strong>BCRX<\/strong>), a leader in the use of crystallography and structure-based drug design; \u00a0Gilead Sciences (<strong>GILD<\/strong>), a leader in HIV and other immunodeficiency treatments; and hardware supplier Fastenal (<strong>FAST<\/strong>). Although we do not currently recommend large cap health care as shown by our 2 (Sell) rating on the StateStreet Select Health Care SPDR ETF <strong>XLV<\/strong>, there are a number of biotech stocks that are recommended now for consideration for potential purchase.<\/p>\n<p>Two new ValuEngine downgrades are in two of the industries most affected by the increases in fuel prices and global fighting.\u00a0 Airline JetBlue (<strong>JBLU<\/strong>) has been downgraded to 2 (Sell), and logistics provider RXO Inc. (<strong>RXO<\/strong>) has also been downgraded to 2.\u00a0 These companies will be challenged to maintain positive earnings streams until fuel prices stabilize and shipping businesses return to something resembling normalcy.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.valuengine.com\/\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=http:\/\/www.valuengine.com\/&amp;source=gmail&amp;ust=1760454514815000&amp;usg=AOvVaw0jaArNHd8Bz74iU3wHHl0F\">www.ValuEngine.com<\/a>\u00a0(<wbr \/>Valuengine, Inc) is a stock valuation and forecasting service founded by Ivy League finance academics. VE utilizes the most advanced quantitative techniques and analysis available to analyze over 4,200 US stocks, 700 US ETFs, and 1,000 Canadian stocks. Fair market valuations, forecast target prices, and buy\/hold\/sell recommendations are updated DAILY.<\/p>\n<p><a href=\"http:\/\/www.valuenginecapital.com\/\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=http:\/\/www.valuenginecapital.com\/&amp;source=gmail&amp;ust=1760454514815000&amp;usg=AOvVaw22EhPOkTAIkAbJq7vZ7au9\">www.ValuEngineCapital.com<\/a>\u00a0(<wbr \/>ValuEngine Capital Management, LLC) is a Registered Investment Advisory firm that trades a variety of different portfolios based upon the ValuEngine.com research models. Each portfolio has a different risk\/return profile, so clients can be placed in strategies that fit their specific investment needs.<\/p>\n<p><a href=\"http:\/\/blog.valuengine.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">BLOG.VALUENGINE.COM\u00a0<\/a>for the full history of ValuEngine.com financial blog posts<\/p>\n<p>____________________________________________________________________________<\/p>\n<p>Existing subscribers alert: ValuEngine has launched a completely redesigned and new website! Please check it out at\u00a0<a href=\"http:\/\/www.valuengine.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">www.Valu<\/a><a href=\"http:\/\/www.valuengine.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">E<\/a><a href=\"http:\/\/www.valuengine.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">ngine.com<\/a><\/p>\n<p>5,000 stocks, 600 ETFs, 16 sector groups, and 140 industries updated on\u00a0<a href=\"http:\/\/www.valuengine.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">www.ValuEngine.com<\/a><\/p>\n<p>Full Two Week Free Trial\u00a0<a href=\"http:\/\/www.valuengine.com\/pub\/VeSubscribeInfo\" target=\"_blank\" rel=\"noopener noreferrer\">HERE<\/a><\/p>\n<p>Financial Advisory Services based on ValuEngine research available through\u00a0<a href=\"http:\/\/www.valuenginecapital.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">www.ValuEngineCapital.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Weekly Market Recap \u2013 Week Ending April 02, 2026 U.S. equity markets continued their upward momentum over the past week, with broad-based gains across major sectors led by technology, industrials, and small-cap stocks. Growth-oriented ETFs, such as the NASDAQ 100 and Technology Select Sector, stood out with strong advances that reflect renewed investor confidence in &#8230; <a title=\"04\/06\/2026 ValuEngine Weekly Market Summary &#038; Commentary\" class=\"read-more\" href=\"http:\/\/blog.valuengine.com\/index.php\/04-06-2026-valuengine-weekly-market-summary-commentary\/\" aria-label=\"More on 04\/06\/2026 ValuEngine Weekly Market Summary &#038; Commentary\">Read more<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[3097,3099,3100,3104,299,3103,1452,2717,1379,3046,1760,1761,1719,3101,3105,2988,1731,873,3107,2832,2835,2897,1819,2006,1510,1911,1938,3102,3106,1748,1818,2802,2801,1074,3098,28,1659,63,2356,990,3073,2121,2085,2277,1849,2279,1887,1814,2707,1900,2276,2278],"_links":{"self":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3865"}],"collection":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/comments?post=3865"}],"version-history":[{"count":1,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3865\/revisions"}],"predecessor-version":[{"id":3868,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3865\/revisions\/3868"}],"wp:attachment":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/media?parent=3865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/categories?post=3865"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/tags?post=3865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}